Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Asset Utilization Ratio: 2009-2025

Historic Asset Utilization Ratio for Aytu Biopharma (AYTU) over the last 14 years, with Sep 2025 value amounting to 0.51.

  • Aytu Biopharma's Asset Utilization Ratio fell 6.47% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year decrease of 6.47%. This contributed to the annual value of 0.55 for FY2025, which is 7.00% up from last year.
  • Latest data reveals that Aytu Biopharma reported Asset Utilization Ratio of 0.51 as of Q3 2025, which was down 4.35% from 0.53 recorded in Q2 2025.
  • Aytu Biopharma's Asset Utilization Ratio's 5-year high stood at 0.76 during Q2 2023, with a 5-year trough of 0.24 in Q2 2021.
  • For the 3-year period, Aytu Biopharma's Asset Utilization Ratio averaged around 0.61, with its median value being 0.55 (2025).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first spiked by 158.21% in 2022, then plummeted by 30.28% in 2024.
  • Quarterly analysis of 5 years shows Aytu Biopharma's Asset Utilization Ratio stood at 0.36 in 2021, then skyrocketed by 99.53% to 0.72 in 2022, then fell by 5.92% to 0.68 in 2023, then declined by 22.36% to 0.53 in 2024, then dropped by 6.47% to 0.51 in 2025.
  • Its last three reported values are 0.51 in Q3 2025, 0.53 for Q2 2025, and 0.55 during Q1 2025.